Research
Macro partitioning
Orlistat produces minimal weight loss (2.78-3.16%) and has a high gastrointestinal side effect profile, making it a less effective first-line treatment compared to GLP-1RAs.
Orlistat is an over-the-counter medication that produces minimal weight loss (approx 3%). It has significant gastrointestinal side effects and is considered less effective than prescription options like GLP-1RAs. It is not recommended as a first-line treatment.
GoodRefutesHIGH confidence
Orlistat reduced mean body weight percentage by 2.78% (95% CI: 2.36%–3.20%)... Orlistat provides little meaningful weight loss and a high gastrointestinal side effect profile and should be avoided as a first-line treatment for obesity.
Why this rating
Supported by multiple meta-analyses.
Source
Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
Andrew Overholser et al. · Translation The University of Toledo Journal of Medical Sciences · 2025
DOI 10.46570/utjms-2024-1218
narrative_reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Tirzepatide (a dual GLP-1RA/GIP agonist) produces superior mean weight loss (18.4%) compared to other FDA-approved pharmacotherapies for obesity, including semaglutide, phentermine-topiramate, and orlistat.Good
- Semaglutide (a GLP-1RA) produces significant weight loss (10-12.5%) and improves cardiometabolic risk factors, making it more effective than older pharmacotherapies like Phentermine-Topiramate and Orlistat.Good
- Phentermine-Topiramate produces moderate weight loss (7.87-8.45%) and improves cardiometabolic risk factors, but carries higher risks of neuropsychiatric and cardiovascular side effects compared to GLP-1RAs.Good
Related findings · Macro partitioning
- Total daily protein intake of 1.6 g/kg/day is sufficient for maximizing resistance training-induced muscle gains, with an upper confidence interval of 2.2 g/kg/day.Strong
- Resistance exercise training combined with sufficient dietary protein intake acts synergistically to maximize skeletal muscle hypertrophy, with protein intake saturating around 1.6 g/kg/day for general populations and potentially requiring 2.0-2.2 g/kg/day for resistance-trained individuals.Strong
- Trans fats should be completely eliminated from the diet, as they increase LDL cholesterol, decrease HDL cholesterol, and are directly associated with increased coronary risk.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →